Richard P. Rieger
Plus aucun poste en cours
Profil
Richard P.
Rieger worked as Vice President of Business Development at Dendreon Corp.
and PhaseRx, Inc. He also worked as Vice President of Commercial Operations at Catalyst Pharmaceuticals, Inc. Rieger received an undergraduate degree from the University of Notre Dame and an MBA from the University of Chicago.
Anciens postes connus de Richard P. Rieger
| Sociétés | Poste | Fin |
|---|---|---|
| PHASERX, INC. | Corporate Officer/Principal | - |
| CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| DENDREON CORPORATION | Corporate Officer/Principal | - |
Formation de Richard P. Rieger
| The University of Chicago | Masters Business Admin |
| University of Notre Dame | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHASERX, INC. | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
